Unity Biotechnology Inc (UBX) — Financial Flexibility Index
Unity Biotechnology Inc (UBX) has a Financial Flexibility Index of -0.21x as of March 2025. Free cash flow of $-6.36 Million (operating CF $-6.36 Million minus capex $0.00) represents 0% of total liabilities ($30.55 Million). Check Unity Biotechnology Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Unity Biotechnology Inc Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Unity Biotechnology Inc across 9 annual periods. For the full cash flow conversion analysis, see Unity Biotechnology Inc cash conversion from operations.
Annual Financial Flexibility Index for Unity Biotechnology Inc (2016–2024)
Year-by-year free cash flow to debt coverage for Unity Biotechnology Inc. Explore Unity Biotechnology Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.67x | $-20.86 Million | $-20.86 Million | $31.17 Million | ▲ +35.4% |
| 2023 | -1.04x | $-38.64 Million | $-38.65 Million | $37.29 Million | ▼ -17.0% |
| 2022 | -0.89x | $-50.93 Million | $-51.03 Million | $57.50 Million | ▼ -28.6% |
| 2021 | -0.69x | $-44.87 Million | $-45.06 Million | $65.14 Million | ▲ +34.9% |
| 2020 | -1.06x | $-77.69 Million | $-78.33 Million | $73.44 Million | ▲ +54.4% |
| 2019 | -2.32x | $-70.83 Million | $-72.42 Million | $30.51 Million | ▲ +13.3% |
| 2018 | -2.68x | $-55.36 Million | $-56.62 Million | $20.68 Million | ▲ +18.4% |
| 2017 | -3.28x | $-36.67 Million | $-38.36 Million | $11.18 Million | ▼ -3101.8% |
| 2016 | -0.10x | $-14.15 Million | $-16.40 Million | $138.18 Million | — |